Carboxylic acid salts
Medchemexpress LLC Tasurgratinib succinate | 1879965-80-6 | 99.2% | 705.8 g/mol | C32H37N5O6.3/2C4H6O4 | 10 MG
Tasurgratinib succinate (E7090) is an orally available, selective inhibitor of fibroblast growth factor receptors FGFR1-3 used in preclinical oncology research. It potently inhibits FGFR signaling at low-nanomolar concentrations and has demonstrated antiproliferative activity in FGFR-driven cancer cell lines.
- Selective FGFR1-3 inhibition with low-nanomolar potency.
- Demonstrated antiproliferative activity in FGFR-driven cell lines.
- Supplied as the succinate salt for preclinical experiments.
- High purity suitable for biochemical and cellular assays.
- Provided in small-mass packages for research use.
Medchemexpress LLC Tasurgratinib succinate | 1879965-80-6 | 99.2% | 764.82 g·mol⁻¹ | C32H37N5O6 · 3/2 C4H6O4 | 5 MG
Tasurgratinib succinate is the succinate salt of an orally active, selective inhibitor of FGFR1-3 used in preclinical and research applications. The compound shows low-nanomolar potency against FGFR1, FGFR2, and FGFR3 and is supplied as a high-purity solid or as a DMSO solution for laboratory studies.
- High purity suitable for research use.
- Potent FGFR1/2/3 inhibition at low nanomolar concentrations.
- Available as solid and as DMSO solution for assay flexibility.
- Soluble in DMSO at high concentration (≈100 mg/mL).
- Pack sizes appropriate for preclinical experiments.
Medchemexpress LLC Chpg sodium salt | 1303993-73-8 | 99.3% | 223.59 g/mol | C8H7ClNNaO3 | 1 ML
CHPG sodium salt is a selective metabotropic glutamate receptor 5 (mGluR5) agonist provided as a 10 mM solution in DMSO for research use. It has been used to study ERK and Akt signaling, oxidative stress, and neuroinflammation in cellular and in vivo models.
- Selective mGluR5 agonist useful for receptor activation studies.
- Supplied as a ready-to-use 10 mM solution in DMSO.
- High purity suitable for research applications.
- Characterized chemical identity with CAS 1303993-73-8.
- Recommended storage at -80°C for long-term or -20°C for short-term, sealed and away from moisture.
Sigma Aldrich Fine Chemicals Biosciences Glycerol phosphate disodium salt hydrate isomeric mixture | 55073-41-1 | MFCD00149082 | 25G
Glycerol phosphate disodium salt hydrate isomeric mixture | 55073-41-1 | MFCD00149082 | 25G
Apexbio Technology LLC Rigosertib sodium salt 1225497-78-8 100mg
Rigosertib sodium salt (CAS 1225497-78-8) is a selective inhibitor targeting Polo-like kinase 1 (PLK1) with reported IC50 approximately 9 nM The compound notably decreases proliferation of cancer cell lines demonstrating nanomolar IC50 values in HeLa (115 nM) and C33A (45 nM) cells whereas normal cells (e g BJ and Ect1/E6E7) remain largely unaffected At concentrations exceeding 0 5 M rigosertib robustly induces G2/M phase arrest in cancer cells without significant cell cycle disruption at lower doses Additionally in vivo studies suggest its potential as a radiosensitizer in cervical carcinoma research
![eMolecules Broadpharm / 44-bis(octyloxy)butanoic acid sodium salt / 250mg / 698443044 / BP-27928 / 95.000 / / [null] / 366.518 / C20H39NaO4](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502475231.JPG-250.jpg)
eMolecules Broadpharm / 44-bis(octyloxy)butanoic acid sodium salt / 250mg / 698443044 / BP-27928 / 95.000 / / [null] / 366.518 / C20H39NaO4
Broadpharm / 44-bis(octyloxy)butanoic acid sodium salt / 250mg / 698443044 / BP-27928 / 95.000 / / [null] / 366.518 / C20H39NaO4
Medchemexpress LLC DG013A (formate) | 00-00-0 | 99.6% | 530.99 g/mol | C27H37N4O4P · 2/5CH2O2 | 5 MG
DG013A (formate) is a phosphinic acid tripeptide mimetic inhibitor of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2, used as a biochemical probe in studies of antigen processing, autoimmune disease, and cancer research. Reported biochemical potency supports use in enzyme inhibition assays and target-validation studies.
- Phosphinic acid tripeptide mimetic inhibitor of ERAP enzymes.
- Potent activity: ERAP1 IC50 33 nM, ERAP2 IC50 11 nM.
- High purity by LCMS: 99.6%.
- Molecular weight: 530.99 g/mol.
- Storage: powder -20°C; in solvent -80°C (6 months) or -20°C (1 month).
- Provided for research use; not for human or clinical use.
Cambridge Isotope Laboratories DIETHYL SUCCINATE (1,2,3,4-13C4, 99%), 0.1 G
DIETHYL SUCCINATE (1,2,3,4-13C4, 99%), 0.1 G
![eMolecules ChemScene / Ruthenium(III) acetate / 250mg / 536799475 / CS-0084981 / 0.000 / 72196-32-8 / [null] / 278.200 / C6H9O6Ru](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502440014.PNG-250.jpg)
eMolecules ChemScene / Ruthenium(III) acetate / 250mg / 536799475 / CS-0084981 / 0.000 / 72196-32-8 / [null] / 278.200 / C6H9O6Ru
ChemScene / Ruthenium(III) acetate / 250mg / 536799475 / CS-0084981 / 0.000 / 72196-32-8 / [null] / 278.200 / C6H9O6Ru
Medchemexpress LLC Cyclic-di-GMP diammonium | 609343-82-0 | MFCD32708541 | 99.1% | 724.47 | C20H30N12O14P2 | 10 MG
Cyclic-di-GMP diammonium is a cyclic dinucleotide research reagent that functions as a STING agonist and a bacterial second messenger. It coordinates bacterial behaviors such as motility, virulence, biofilm formation, and cell cycle progression, and has reported activity in cellular assays including effects on cell proliferation and CD4 receptor expression. Supplied as the diammonium salt for laboratory research.
- Used for STING activation and bacterial second-messenger studies.
- Shows activity in cell proliferation and CD4 receptor expression assays.
- Supplied as a diammonium salt; chemical formula C20H30N12O14P2.
- Molecular weight 724.47.
- Purity 99.07%.
- Available in small research quantities suitable for in vitro experiments.